medigraphic.com
ISSN 0185-3325 (Impreso)
Órgano Oficial del Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz

2020, Número 1

<< Anterior Siguiente >>

Salud Mental 2020; 43 (1)


Does the antidepressant-like effect of mirtazapine and venlafaxine differ between male and female rats?

Álvarez SA, Fernández-Guasti A

Idioma: Ingles.
Referencias bibliográficas: 42
Paginas: 11-19
Archivo PDF: 347.23 Kb.


RESUMEN

Introducción. La depresión es un trastorno psiquiátrico que representa un problema de salud mundial. Afecta a cerca de 350 millones de personas, predominantemente mujeres. Sin embargo, algunos reportes indican que su incidencia en hombres está aumentando, por lo que es necesario buscar opciones de tratamiento que sean igualmente efectivas en ambos sexos. Objetivo. Analizar si existen diferencias relacionadas con el sexo en el efecto de tipo antidepresivo de la mirtazapina y la venlafaxina, y considerar los posibles mecanismos neuroquímicos involucrados. Método. se administraron mirtazapina (40 mg/kg) o venlafaxina (60 mg/kg) en esquema subcrónico a grupos independientes de ratas macho y hembra ovariectomizadas tratadas con estradiol y progesterona. Se evaluaron el efecto tipo antidepresivo y las conductas activas (nado y escalamiento) utilizando la prueba de nado forzado (PNF). Resultados. a) tanto la mirtazapina como la venlafaxina redujeron la inmovilidad en la PNF en machos y hembras; b) ambos antidepresivos incrementaron las conductas activas en machos; c) en hembras, la mirtazapina y la venlafaxina produjeron un aumento del nado, pero no modificaron el escalamiento. Discusión y conclusión. En machos, los efectos de la mirtazapina y la venlafaxina en la PNF se deben a su acción sobre los sistemas serotonérgico y noradrenérgico; en cambio, en hembras sólo se modifica la conducta de nado, lo que sugiere que el estradiol modula las acciones de ambos antidepresivos sobre el sistema serotoninérgico.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Addis, M. E. (2008). Gender and depression in men. Clinical Psychology: Science and Practice, 15(3), 153-168. doi: 10.1111/j.1468-2850.2008.00125.x

  2. Álvarez-Silva, A. A., & Fernández-Guasti, A. (2019). The combination of mirtazapine plus venlafaxine reduces immobility in the forced swim test and does not inhibit female sexual behavior. Pharmacology, Biochemistry and Behavior, 187, 172817 doi: 10.1016/j.pbb.2019.172817

  3. Anttila, S. A., & Leinonen, E. V. (2001). A review of the pharmacological and clinical profile of mirtazapine. CNS Drug Reviews, 7(3), 249-264. doi: 10.1111/j.1527- 3458.2001.tb00198.x

  4. Barros, H. M., & Ferigolo, M. (1998). Ethopharmacology of imipramine in the forced swimming test: gender differences. Neuroscience & Biobehavioral Reviews, 23(2), 279-286. doi: 10.1016/S0149-7634(98)00029-3

  5. Berlanga, C., & Flores-Ramos, M. (2006). Different gender responses to serotonergic and noradrenergic antidepressants. A comparative study of the efficacy of citalopram and reboxetine. Journal of Affective Disorders, 95(1-3), 119-123. doi: 10.1016/j.jad.2006.04.029

  6. Bertrand, P. P., Paranavitane, U. T., Chavez, C., Gogos, A., Jones, M., & van den Buuse, M. (2005). The effect of low estrogen state on serotonin transporter function in mouse hippocampus: a behavioral and electrochemical study. Brain Research, 1064(1-2), 10-20. doi: 10.1016/j.brainres.2005.10.018

  7. de Boer, T., Ruigt, G. S. F., & Berendsen, H. H. G. (1995). The α2-selective adrenoceptor antagonist org 3770 (mirtazapine, Remeron®) enhances noradrenergic and serotonergic transmission. Human Psychopharmacology: Clinical and Experimental, 10(S2), S107-S118. doi: 10.1002/hup.470100805

  8. Bogdanova, O. V., Kanekar, S., D’Ancy, K. E., & Renshaw, P. F. (2013). Factors influencing behavior in the forced swim test. Physiology and Behavior, 118, 227-239. doi: 10.1016/j.physbeh.2013.05.012

  9. Cochran, S. V., & Rabinowitz, F. E. (2000). Men and depression: Clinical and empirical perspectives. San Diego, California: Academic Press. ISBN 0-12- 177540-2

  10. Dalla, C., Antoniou, K., Kokras, N., Drossopoulou, G., Papathanasiou, G., Bekris, S., ... Papadopoulou-Daifoti, Z. (2008). Sex differences in the effects of two stress paradigms on dopaminergic neurotransmission. Physiology & Behavior, 93(3), 595-605. doi: 10.1016/j.physbeh.2007.10.020

  11. Dalla, C., Pitychoutis, P. M., Kokras, N., & Papadopoulou-Daifoti, Z. (2010). Sex differences in animal models of depression and antidepressant response. Basic & Clinical Pharmacology & Toxicology, 106(3), 226-233. doi: 10.1111/j.1742- 7843.2009.00516.x

  12. Davis, R., & Wilde, M. I. (1996). Mirtazapine: A review of its pharmacology and therapeutic potential in the management of major depression. CNS Drugs, 5(5), 389-402. doi: 10.2165/00023210-199605050-00007

  13. Detke, M. J., Rickels, M., & Lucki, I. (1995). Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology, 121(1), 66-72. doi: 10.1007/ BF02245592

  14. Drossopoulou, G., Antoniou, K., Kitraki, E., Papathanasiou, G., Papalexi, E., Dalla, C., & Papadopoulou-Daifoti, Z. (2004). Sex differences in behavioral, neurochemical and neuroendocrine effects induced by the forced swim test in rats. Neuroscience, 126(4), 849-857. doi: 10.1016/j.neuroscience.2004.04.044 Estrada-Camarena, E., Fernández-Guasti, A., & López-Rubalcava, C. (2003). Antidepressant-like effect of different estrogenic compounds in the forced swimming test. Neuropsychopharmacology, 28(5), 830-838. doi: 10.1038/ sj.npp.1300097

  15. Estrada-Camarena, E., Rivera, N. V., Berlanga, C., & Fernández-Guasti, A. (2008). Reduction in the latency of action of antidepressants by 17-β estradiol in the forced swimming test. Psychopharmacology, 201(3), 351-360. doi: 10.1007/ s00213-008-1291-8

  16. Estrada-Camarena, E., López-Rubalcava, C., Hernández-Aragón, A., Mejía- Mauries, S., & Picazo, O. (2011). Long-term ovariectomy modulates the antidepressant-like action of estrogens, but not of antidepressants. Journal of Psychopharmacology, 25(10), 1365-1377. doi: 10.1177/0269881111408456

  17. Fernández-Guasti, A., Olivares-Nazario, M., Reyes, R., & Martínez-Mota, L. (2017). Sex and age differences in the antidepressant-like effect of fluoxetine in the forced swim test. Pharmacology, Biochemistry and Behavior, 152, 81-89. doi: 10.1016/j.pbb.2016.01.011

  18. Gómez, M. L., Martinez-Mota, L., Estrada-Camarena, E., & Fernandez-Guasti, A. (2014). Influence of the brain sexual differentiation process on despair and antidepressant-like effect of fluoxetine in the rat forced swim test. Neuroscience, 261, 11-22. doi: 10.1016/j.neuroscience.2013.12.035

  19. Gray, V. C., & Hughes, R. N. (2015). Drug-, dose- and sex-dependent effects of chronic fluoxetine, reboxetine and venlafaxine on open-field behavior and spatial memory in rats. Behavioural Brain Research, 281, 43-54. doi: 10.1016/j. bbr.2014.12.023

  20. Hernández, A., & Fernández-Guasti, A. (2018). Male rats with same-sex preference show higher immobility in the forced swim test, but similar effects of fluoxetine and desipramine than males that prefer females. Pharmacology, Biochemistry and Behavior, 171, 39-45. doi: 10.1016/j.pbb.2018.05.017

  21. Hernández-Munive, A. K., Rebolledo-Solleiro, D., Ventura-Aquino, E., & Fernández- Guasti, A. (2018). Reduced lordosis and enhanced aggression in paced and nonpaced mating in diabetic female rats. The Journal of Sexual Medicine, 15(2), 124-135. doi: 10.1016/j.jsxm.2017.11.018

  22. Holliday, S. M., & Benfield, P. (1995). Venlafaxine: A review of its pharmacology and therapeutic potential in depression. Drugs, 49(2), 280-294. doi: 10.2165/00003495-199549020-00010

  23. Khan, A., Brodhead, A. E., Schwartz, K. A., Kolts, R. L., & Brown, W. A. (2005). Sex differences in antidepressant response in recent antidepressant clinical trials. Journal of Clinical Psychopharmacology, 25(4), 318-324. doi: 10.1097/01. jcp.0000168879.03169.ce

  24. Kokras, N., Antoniou, K., Dalla, C., Bekris, S., Xagoraris, M., Ovestreet, D. H., & Papadopoulou-Daifoti, Z. (2009). Sex-related differential response to clomipramine treatment in a rat model of depression. Journal of Psychopharmacology, 23(8), 945-956. doi: 10.1177/0269881108095914

  25. Koldzic-Zivanovic, N., Seitz, P. K., Watson, C. S., Cunningham, K. A., & Thomas, M. L. (2004). Intracellular signaling involved in estrogen regulation of serotonin reuptake. Molecular and Cellular Endocrinology, 226(1-2), 33-42. doi: 10.1016/j.mce.2004.07.017

  26. Kornstein, S. G., Schatzberg, A. F., Thase, M. E., Yonkers, K. A., McCullough, J. P., Keitner, G. I., ... Keller, M. B. (2000). Gender differences in treatment response to sertraline versus imipramine in chronic depression. American Journal of Psychiatry, 157(9), 1445-1452. doi: 10.1176/appi.ajp.157.9.1445

  27. Martenyi, F., Dossenbach, M., Mraz, K., & Metcalfe, S. (2001). Gender differences in the efficacy of fluoxetine and maprotiline in depressed patients: a doubleblind trial of antidepressants with serotonergic or norepinephrinergic reuptake inhibition profile. European Neuropsychopharmacology, 11(3), 227-232. doi: 10.1016/S0924-977X(01)00089-X

  28. Melo, T. G., Izídio, G. S., Ferreira, L. S., Sousa, D. S., Macedo, P. T., Cabral, A., ... Silva, R. H. (2012). Antidepressants differentially modify the extinction of an aversive memory task in female rats. Progress in Neuro-psychopharmacology and Biological Psychiatry, 37(1), 33-40. doi: 10.1016/j.pnpbp.2012.01.012

  29. Millan, M. J., Gobert, A., Lejeune, F., Newman-Tancredi, A., Rivet, J. M., Auclair, A., & Peglion, J. L. (2001). S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine. Journal of Pharmacology and Experimental Therapeutics, 298(2), 565-580.

  30. Mize, A. L., Young, L. J., & Alper, R. H. (2003). Uncoupling of 5-HT1A receptors in the brain by estrogens: regional variations in antagonism by ICI 182,780. Neuropharmacology, 44(5), 584-591. doi: 10.1016/S0028-3908(03)00044-3

  31. Molendijk, M. L., & de Kloet E. R. (2015). Immobility in the forced swim test is adaptative and does not reflect depression. Psychoneuroendocrinology, 62, 389- 391. doi: 10.1016/j.psyneuen.2015.08.028

  32. de Montigny, C., Haddjeri, N., Mongeau, R., & Blier, P. (1995). The effects of mirtazapine on the interactions between central noradrenergic and serotonergic systems. CNS Drugs, 4(1), 13-17. doi: 10.2165/00023210-199500041-00004 Rénéric, J. P., & Lucki, I. (1998). Antidepressant behavioral effects by dual inhibition of monoamine reuptake in the rat forced swimming test. Psychopharmacology, 136(2), 190-197. doi: 10.1007/s002130050555

  33. Rénéric, J. P., Bouvard, M., & Stinus, L. (2002). In the rat forced swimming test, NAsystem mediated interactions may prevent the 5-HT properties of some subacute antidepressant treatments being expressed. European Neuropsychopharmacology, 12(2), 159-171. doi: 10.1016/S0924-977X(02)00007-X

  34. Rogóz, Z., Kabziἠzki, M., Sadaj, W., Rachwalska, P., & Gᶏdek-Michalska, A. (2012). Effect of co-treatment with fluoxetine or mirtazapine and risperidone on the active behaviors and plasma corticosterone concentration in rats subjected to the forced swim test. Pharmacological Reports, 64(6), 1391-1399. doi: 10.1016/ S1734-1140(12)70936-2

  35. Šagud, M., Hotujac, L. J., Mihaljević-Pelleš, A., & Jakovljević, M. (2002). Gender differences in depression. Collegium Antropologicum, 26(1), 149-157.

  36. Schmidt, M. E., Matochik, J. A., Goldstein, D. S., Schauten, J. L., Zametkin, A. J., & Potter, W. Z. (1997). Gender differences in brain metabolic and plasma catecholamine responses to alpha2-adrenoceptor blockade. Neuropsychopharmacology, 16(4), 298-310. doi: 10.1016/S0893- 133X(96)00264-3

  37. Slattery, D. A., & Cryan, J. F. (2012). Using the rat forced swim test to assess antidepressant-like activity in rodents. Nature Protocols, 7(6), 1009-1014. doi: 10.1038/nprot.2012.044

  38. Sramek, J. J., Murphy, M. F., & Cutler, N. R. (2016). Sex differences in the psychopharmacological treatment of depression. Dialogues in Clinical Neuroscience, 18(4), 447-457.

  39. Vega-Rivera, N. M., Fernández-Guasti, A., Ramírez-Rodríguez, G., & Estrada-Camarena, E. (2013a). Acute stress further decreases the effect of ovariectomy on immobility behavior and hippocampal cell survival in rats. Psychoneuroendocrinology, 38(8), 1407-1417. doi: 10.1016/j. psyneuen.2012.12.008

  40. Vega-Rivera, N. M., López-Rubalcava, C., & Estrada-Camarena, E. (2013b). The antidepressant-like effect of ethynyl estradiol is mediated by both serotonergic and noradrenergic systems in the forced swimming test. Neuroscience, 250, 102-111. doi: 10.1016/j.neuroscience.2013.06.058

  41. World Health Organization. (2018). Depresión. Retrieved from: https://www.who.int/ es/news-room/fact-sheets/detail/depression

  42. Xing, Y., He, J., Hou, J., Lin, F., Tian, J., & Kurihara, H. (2013). Gender differences in CMS and the effect of antidepressant venlafaxine in rats. Neurochemistry International, 63(6), 570-575. doi: 10.1016/j.neuint.2013.09.019




2020     |     www.medigraphic.com